Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study
Authors:
- Kuo-Chang WenKWKuo-Chang Wen
- Rui-Lan HuangRHRui-Lan Huang
- Lin-Yu ChenLCLin-Yu Chen
- Tzu-I WuTWTzu-I Wu
- Chien-Hsing LuCLChien-Hsing Lu
- Tang-Yuan ChuTCTang-Yuan Chu
- Yu-Che OuYOYu-Che Ou
- Chen-Hsuan WuCWChen-Hsuan Wu
- Shih-Tien HsuSHShih-Tien Hsu
- Dah-Ching DingDah-Ching Ding
- Ling-Hui ChuLCLing-Hui Chu
- Chien-Wen ChenCCChien-Wen Chen
Open Access
Abstract
Background: We describe a DNA methylation assay, named MPap test, using cervical scraping as an alternative technique for endometrial cancer detection. Methods: A multicenter hospital-based, two-stage validation study was conducted to validate the cancer detection performance of the MPap test. The MPap value was determined from the DNA methylation status of two genes (BHLHE22, CDO1) and combined with two other clinical variables (age, BMI). The cutoff threshold of the MPap value was established in stage 1 and validated in stage 2. A total of 592 women with abnormal uterine bleeding were enrolled from five medical centers throughout Taiwan. Results: In stage 1, the sensitivity, specificity, and positive and negative predictive values of the MPap test for detecting endometrial cancer were 92.9%, 71.5%, 39.8%, and 98.0%, respectively. These values were validated in stage 2, being 92.5%, 73.8%, 40.2%, and 98.1%. Moreover, MPap outperformed transvaginal ultrasound in sensitivity and negative predictive values for detecting endometrial cancer. When we applied the algorithm for triage of endometrial cancer detection by MPap in the Taiwan National Health Insurance dataset, we found that it may reduce invasive procedures by 69~73%. Conclusions: MPap may provide a feasible alternative for endometrial cancer detection and can be considered as a triage test to reduce unnecessary invasive procedures.Keywords
Funding Information
- Ministry of Health and Welfare (MOHW105–TDU–PB–212–000007, MOST106–3114–B–038–003, MOST107–2321–B–038–003, MOST107–2321–B–038–006, MOST110–2314–B–038–059, MOST111–2314–B–038–110–MY2, 106TMU-SHH–14, TMU108-AE1-B54)
- Ministry of Science and Technology of Taiwan (MOHW105–TDU–PB–212–000007, MOST106–3114–B–038–003, MOST107–2321–B–038–003, MOST107–2321–B–038–006, MOST110–2314–B–038–059, MOST111–2314–B–038–110–MY2, 106TMU-SHH–14, TMU108-AE1-B54)
- Shuang Ho Hospital-Taipei Medical University (MOHW105–TDU–PB–212–000007, MOST106–3114–B–038–003, MOST107–2321–B–038–003, MOST107–2321–B–038–006, MOST110–2314–B–038–059, MOST111–2314–B–038–110–MY2, 106TMU-SHH–14, TMU108-AE1-B54)
This publication has 35 references indexed in Scilit:
- The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
- Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept StudyJournal of Clinical Oncology, 2015
- Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tamponsGynecologic Oncology, 2015
- Sample size estimation in diagnostic test studies of biomedical informaticsJournal of Biomedical Informatics, 2014
- Discovery and validation of methylation markers for endometrial cancerInternational Journal of Cancer, 2014
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortThe Lancet Oncology, 2011
- How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleedingUltrasound in Obstetrics & Gynecology, 2004
- The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol dataBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- Complications of hysteroscopy: a prospective, multicenter studyObstetrics & Gynecology, 2000